CD1a APC(111544)
Caprico Biotechnologies CD1a APC catalog number: 111544，The clone OKT6, a mouse monoclonal antibody selectively recognizes 49-kDa type I transmembrane glycoprotein non-covalently associated with β2-microglobulin known as CD1a.
CD1a FITC(111514)
Caprico Biotechnologies CD1a FITC catalog number: 111514，The clone OKT6, a mouse monoclonal antibody selectively recognizes 49-kDa type I transmembrane glycoprotein non-covalently associated with β2-microglobulin known as CD1a.
CD1a iFluor647(1115124)
Caprico Biotechnologies CD1a iFluor647 catalog number: 1115124，The clone OKT6, a mouse monoclonal antibody selectively recognizes 49-kDa type I transmembrane glycoprotein non-covalently associated with β2-microglobulin known as CD1a.
CD1a PE(111524)
Caprico Biotechnologies CD1a PE catalog number: 111524，The clone OKT6, a mouse monoclonal antibody selectively recognizes 49-kDa type I transmembrane glycoprotein non-covalently associated with β2-microglobulin known as CD1a.
CD1a PE-Cyanine5(111574)
Caprico Biotechnologies CD1a PE-Cyanine5 catalog number: 111574，The clone OKT6, a mouse monoclonal antibody selectively recognizes 49-kDa type I transmembrane glycoprotein non-covalently associated with β2-microglobulin known as CD1a.
CD1a PE-Cyanine7(111584)
Caprico Biotechnologies CD1a PE-Cyanine7 catalog number: 111584，The clone OKT6, a mouse monoclonal antibody selectively recognizes 49-kDa type I transmembrane glycoprotein non-covalently associated with β2-microglobulin known as CD1a.
CD1a PerCP-Cyanine5.5(111564)
Caprico Biotechnologies CD1a PerCP-Cyanine5.5 catalog number: 111564，The clone OKT6, a mouse monoclonal antibody selectively recognizes 49-kDa type I transmembrane glycoprotein non-covalently associated with β2-microglobulin known as CD1a.
CD1a Unconjugated(111501)
Caprico Biotechnologies CD1a Unconjugated catalog number: 111501，The clone OKT6, a mouse monoclonal antibody selectively recognizes 49-kDa type I transmembrane glycoprotein non-covalently associated with β2-microglobulin known as CD1a.
ALTIRATINIB (DCC-2701)
Background Information: Abstract (Ref 1): Altiratinib (DCC-2701) was designed based on the rationale of engineering a single therapeutic agent able to address multiple hallmarks of cancer. Specifically, Altiratinib inhibits not only mechanisms of tumor initiation and...